HIGHLIGHTS
- who: Unknown from the Department of Rheumatologygastroenterology, dermatology, immunology, clinical pharmacy, and outpatient pharmacy of the Erasmus MC, the Netherlands have published the article: Digital Outcome Measurement to Improve Care for Patients With Immune-Mediated Inflammatory Diseases: Protocol for the IMID Registry, in the Journal: (JOURNAL)
- what: The is also used for research purposes and 92% of the patients with IMIDs gave informed consent to use their data for that. The measurement of PROs in daily practice has several potential benefits as they could improve care for the individual patient, provide real-world data for . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.